Bilreiro, CarlosAndrade, LuísaSantiago, InêsMarques, Rui MateusMatos, Celso2024-02-222024-02-222024-062352-0477PURE: 83868733PURE UUID: 1b052c59-a718-43f1-82ae-4e81b8d97b1cScopus: 85184763445http://hdl.handle.net/10362/163914Funding Information: This work did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Publisher Copyright: © 2024Background: Pancreatic ductal adenocarcinoma (PDAC) is a common and lethal cancer. From diagnosis to disease staging, response to neoadjuvant therapy assessment and patient surveillance after resection, imaging plays a central role, guiding the multidisciplinary team in decision-planning. Review aims and findings: This review discusses the most up-to-date imaging recommendations, typical and atypical findings, and issues related to each step of patient management. Example cases for each relevant condition are presented, and a structured report for disease staging is suggested. Conclusion: Despite current issues in PDAC imaging at different stages of patient management, the radiologist is essential in the multidisciplinary team, as the conveyor of relevant imaging findings crucial for patient care.10125790engNeoadjuvant therapyNeoplasm recurrence, LocalNeoplasm stagingPancreatic carcinomaPatient care teamRadiology Nuclear Medicine and imagingSDG 3 - Good Health and Well-beingImaging of pancreatic ductal adenocarcinoma – An update for all stages of patient managementjournal article10.1016/j.ejro.2024.100553https://www.scopus.com/pages/publications/85184763445